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Abstract
Background and Purpose: Post-ischemic oxidative stress and vasomotor dysfunction in cerebral arteries may increase the
likelihood of cognitive impairment and secondary stroke. However, the underlying mechanisms of post-stroke vascular
abnormalities, as distinct from those causing primary brain injury, are poorly understood. We tested whether augmented
superoxide-dependent dysfunction occurs in the mouse cerebral circulation following ischemia-reperfusion, and evaluated
the role of Nox2 oxidase.
Methods: Cerebral ischemia was induced in male C57Bl6/J wild-type (WT) and Nox2-deficient (Nox2
-/-) mice by middle
cerebral artery occlusion (MCAO; 0.5 h), followed by reperfusion (23.5 h). Superoxide production by MCA was measured by
L-012-enhanced chemiluminescence. Nitric oxide (NO) function was assessed in cannulated and pressurized MCA via the
vasoconstrictor response to N
v-nitro-L-arginine methyl ester (L-NAME; 100 mmol/L). Expression of Nox2, the nitration marker
3-nitrotyrosine, and leukocyte marker CD45 was assessed in cerebral arteries by Western blotting.
Results: Following ischemia-reperfusion, superoxide production was markedly increased in the MCA of WT, but not Nox2
-/-
mice. In WT mice, L-NAME-induced constriction was reduced by ,50% in ischemic MCA, whereas ischemia-reperfusion had
no effect on responses to L-NAME in vessels from Nox2
-/- mice. In ischemic MCA from WT mice, expression of Nox2 and 3-
nitrotyrosine were ,1.4-fold higher than in the contralateral MCA, or in ischemic or contralateral vessels from Nox2
-/- mice.
Vascular CD45 levels were unchanged by ischemia-reperfusion.
Conclusions: Excessive superoxide production, impaired NO function and nitrosative stress occur in mouse cerebral arteries
after ischemia-reperfusion. These abnormalities appear to be exclusively due to increased activity of vascular Nox2 oxidase.
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Introduction
Cerebrovascular dysfunction, consisting of deficits in nitric
oxide (NO)-dependent endothelial function and vasodilatation,
occurs early following cerebral ischemia-reperfusion [1]. These
vascular abnormalities may then limit brain perfusion and
accelerate inflammation and death of neuronal tissue within the
compromised but potentially salvageable penumbra, thereby
increasing the risk of secondary stroke and cognitive impairment
[2,3]. Despite progress in understanding primary mechanisms of
neuronal cell death during ischemia [4], translation of that
knowledge into effective stroke therapies has so far been
unsuccessful [5]. Consequently, an increased focus on targeting
key vascular mechanisms for improving stroke outcome has been
advocated [6].
Oxidative stress, characterized by excessive levels of reactive
oxygen species (ROS) such as superoxide and hydrogen peroxide,
is a major cause of neuronal injury after cerebral ischemia-
reperfusion [6]. ROS levels are elevated in the cerebral
vasculature during reperfusion [7,8,9,10,11], and are suspected
to be an underlying cause of post-ischemic endothelial dysfunction
[9,10], however, their enzymatic source(s) is yet to be defined. The
NADPH oxidases are the only enzymes yet discovered with the
primary function of generating superoxide [12], and they are
major sources of ROS in the cerebral vasculature under
physiological conditions [13]. This family of enzymes comprises
two membrane-bound subunits, including a Nox catalytic subunit
and p22phox, as well as different combinations of several
cytoplasmic subunits [12,13]. In cerebral blood vessels, at least
three isoforms of NADPH oxidase are expressed, namely Nox1-,
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[12,13]. The Nox2 oxidase is predominantly expressed in the
endothelial cell layer of cerebral arteries, and this isoform is
emerging as a major source of pathological ROS in cerebral
vessels [14,15,16,17]. Although experimental studies have dem-
onstrated a causative role for Nox2 oxidase in neuronal [18,19,20]
and blood-brain barrier damage [21] after ischemic stroke, it is
unclear whether Nox2 oxidase contributes to increased superoxide
levels and/or endothelial dysfunction in the cerebral circulation
following ischemia-reperfusion. Currently available pharmacolog-
ical inhibitors of Nox oxidases have limited utility for defining
molecular pathways due to their lack of isoform selectivity and/or
their off-target effects [12], and so definitive evidence for a
causative role for any of these enzymes requires the use of
genetically modified mouse models. Therefore, the aim of the
present study was to firstly test whether augmented superoxide
production and endothelial dysfunction occur in the mouse
cerebral circulation following ischemia-reperfusion, and secondly
to evaluate the role of Nox2 oxidase in these effects using Nox2-
deficient mice.
Materials and Methods
All procedures were approved by the institutional animal ethics
committee. In total, 72 male C57Bl6/J wild type (WT,
25.960.3 g) and 24 male Nox2-deficient (Nox2
-/-: 27.360.4 g)
mice were studied. Nox2
-/- mice were originally generated in the
laboratory of Prof. Mary Dinauer [22] and bred at Mouseworks
(Clayton, Australia). Nox2
-/- mice were backcrossed to the
C57Bl6/J strain for at least 10 generations. Mice were studied at
8 to 12 weeks of age and killed by inhalation of isoflurane followed
by decapitation. In all, 15 WT and 6 Nox2
-/- mice were excluded
from the study which occurred when, during the surgical
procedure to induce focal cerebral ischemia-reperfusion: (1) there
was inadequate (,70%) reduction in regional cerebral blood flow
(rCBF) (n=1 for WT and n=1 for Nox2
-/-); or (2) technical or
anaesthesia complications arose during surgery (n=14 for WT
and n=5 for Nox2
-/-).
Focal cerebral ischemia-reperfusion
Mice were anesthetized with a mixture of ketamine (80 mg/kg,
i.p.) and xylazine (10 mg/kg, i.p.). Body temperature was
maintained at 37.5uC with a heat lamp throughout the procedure
and until animals regained consciousness. Focal cerebral ischemia-
reperfusion was performed in mice by transient intraluminal
filament-induced middle cerebral artery occlusion (MCAO) as
previously described [18,20,23]. rCBF in the area of the cortex
supplied by the MCA (approximately 2 mm posterior and 5 mm
lateral to bregma) was monitored and recorded prior to the
induction of cerebral ischemia and for the first 30 min of
reperfusion using trans-cranial laser-Doppler flowmetry. For sham
MCAO surgery, the common carotid artery was visualized, but
the MCA was not occluded.
Evaluation of neurological function, cerebral infarct and
edema volume
At the end of the experiment (24 h), neurological function was
evaluated by an observer blinded to the genotype using the
hanging wire test [18,20,23]. Briefly, mice were suspended from a
wire 30 cm high for up to 60 s and the average hanging time (i.e.
latency to fall) of 3 trials with 5 min rest in between was recorded.
Cerebral infarct and edema volumes at 24 h were also evaluated
as previously described [18,20,23]. Briefly, brains were sectioned
(30 mm coronal sections; 420 mm apart) using a Leica CM1850
cryostat and thaw mounted onto 0.1% poly-L-lysine coated slides.
Sections were immersed in 0.1% thionin (2 min), rinsed with
distilled H2O, then immersed in 70% ethanol (2 min) followed by
100% ethanol (2 min). Sections were then dipped in xylene and
cover slipped with DPX mounting media. Thionin-stained sections
were imaged with a CCD camera (Cohu Inc., San Diego,
California, USA) mounted above a light box (Biotec-Fischer
Colour Control 5000, Reiskirchin, Germany). Total infarct
volume was quantified using ImageJ image analysis software
(Version 1.42q, NIH), correcting for brain edema, according to the
following formula: CIV = [RIA – (RHA – LHA)] 6thickness of
slice (CIV, corrected infarct volume; RIA, right hemisphere infarct
area; RHA, right hemisphere area; LHA, left hemisphere area).
Edema volume was estimated according to the formula: EV =
(RHA – LHA) 6 thickness of slice (EV, Edema volume). Infarct
and edema volumes for all sections were totaled and expressed as
mm
3.
Measurement of superoxide production by middle
cerebral arteries
MCA were isolated from the contralateral (non-ischemic) and
ischemic cerebral hemispheres of WT and Nox2
-/- mice after
23.5 h reperfusion. In addition, MCA from left and right
hemispheres of sham-operated WT mice were isolated. Briefly,
using a dissection microscope, the MCA was located and then
dissected free of the brain, starting ,1–2 mm distal to its origin at
the Circle of Willis and finishing at the end of its second branch.
Basal and phorbol-12, 13-dibutyrate (10 mmol/L; PDB: Nox2
activator)-stimulated superoxide production was measured con-
secutively in the same MCA using 100 mmol/L L-012-enhanced
chemiluminescence and expressed in counts/mg of dry tissue
weight, as previously described [14,16,24].
Assessment of nitric oxide function in middle cerebral
arteries
MCA were isolated from the ischemic and non-ischemic
hemispheres of WT and Nox2
-/- mice after 23.5 h reperfusion,
and were mounted between two microcannulae in a pressure
myograph (Living Systems Instrumentation Inc.). Arteries were
superfused with warm (37uC) carbogen-bubbled (95% O2,5 %
CO2) Krebs-bicarbonate solution (composition in mmol/L; NaCl
118, KCl 4.5, MgSO4 0.45, KH2PO4 1.03, NaHCO3 25, glucose
11.1, CaCl2 2.5). Intraluminal pressure was gradually increased to
60 mmHg and maintained at this level with a pressure servo unit
without further intraluminal perfusion. Each MCA was allowed to
equilibrate for 15 min and baseline diameter was then measured.
Functional experiments were performed on both ischemic and
non-ischemic MCA in parallel, and arteries from a WT and a
Nox2
-/- mouse were typically studied on the same day.
NO function was assessed via the constrictor response to the
NO synthase (NOS) inhibitor, L-NAME (100 mmol/L)
[16,24,25,26]. Constrictor responses were recorded when a steady
level in diameter was reached (after ,30 min). Cumulative
concentration-dependent constrictor responses to either the a1-
adrenoceptor agonist phenylephrine (1–1000 nmol/L) or the
thromboxane A2 mimetic U46619 (1–1000 nmol/L) were also
assessed.
Western Blotting
Ischemic and contralateral MCA were isolated from WT and
Nox2
-/- mice 23.5 h after reperfusion. Protein expression levels of
Nox2, the nitration marker 3-nitrotyrosine, endothelial NOS
(eNOS) and the pan leukocyte marker CD45 were measured in
Nox2 Oxidase and Post-Ischemic Cerebral Arteries
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[14,16,27]. For Nox2, 3-nitrotyrosine and eNOS, ischemic or
contralateral MCA from two mice were pooled for each
experiment. For CD45, spleen homogenates were used as a
positive control. In preliminary experiments, we determined that
30 mg of protein was required to detect CD45 immunoreactivity
(.150 kDa) in spleen homogenates. Therefore, to obtain sufficient
protein, ischemic or contralateral MCA from five mice were
pooled for measurement of CD45 protein. Anti-Nox2 and anti-
eNOS monoclonal antibodies were purchased from BD Biosci-
ences (both 1:1000), anti-3-nitrotyrosine monoclonal antibody and
anti-CD45 polyclonal antibody were from Abcam (both 1:500).
Immunoreactive bands were detected by enhanced chemilumi-
nescence and quantified using a ChemiDoc XRS molecular
imager (BioRad). For Nox2, 3-nitrotyrosine and eNOS, immuno-
reactive bands were normalized to intensity of corresponding
bands for b-actin (Cell Signaling; 1:3000). For CD45 Western
blotting, a 5% polyacrylamide gel was used allow adequate protein
separation above 150 kDa. As such, there was no separation of
proteins ,50 kDa in size and therefore measurement of b-actin
levels was not possible. Therefore, in these experiments, equal
protein loading was confirmed using Ponceau S staining.
Drugs
Ketamine was purchased from Parnell Laboratories (Australia),
L-012 from Wako Pure Chemicals (Japan) and PDB from
Calbiochem (USA). U46619 (in methyl acetate) was purchased
from Sapphire Biosciences (Australia), xylazine from Troy
laboratories (Australia), and all other drugs from Sigma. L-012
and PDB were prepared at 100 mmol/L and 10 mmol/L,
respectively, in 100% DMSO and subsequently diluted in
Krebs-HEPES solution. U46619 was prepared at 1 mmol/L in
100% EtOH and subsequently diluted in Krebs-bicarbonate
solution. All other drugs for myograph experiments were dissolved
and diluted in Krebs-bicarbonate solution. For experiments using
L-012 and PDB, the final concentration of DMSO was #0.2%.
Data analysis
All results are presented as mean6SEM. Statistical comparisons
were performed using one or two-way ANOVA with a Bonferroni
multiple comparison post hoc test, log-rank test, one-sample,
paired or unpaired t test, as appropriate. P,0.05 was considered
statistically significant.
Results
Degree of hypoperfusion, mortality, sensorimotor deficit
and infarct volume
Following insertion of the monofilament in WT or Nox2
-/- mice
(Fig 1A, n=60 for WT and n=22 for Nox2
-/-) cortical rCBF was
reduced by ,75%, indicative of successful MCA occlusion. Upon
withdrawal of the monofilament, flow increased towards 100%
indicative of effective reperfusion and then gradually decreased to
approximately 50% of pre-ischemic levels after 30 min of
reperfusion. In sham-operated WT mice, rCBF remained at
,100% for the duration of the monitoring period (Fig 1A).
Mortality during the 23.5 h reperfusion period was 11/72 (15%)
in WT mice and 1/23 (4%) in Nox2
-/- mice (log-rank test of
survival; P=0.07). Sensorimotor function, as assessed by latency to
fall in the hanging wire test, was significantly greater in Nox2
-/-
mice (37.066.7 s, n=12) than in WT mice (19.864.9 s; n=15,
P,0.05). In sham-operated WT mice, the latency to fall was
57.362.8 s (n=7). Consistent with the protective effects of Nox2
deletion, Nox2
-/- mice had smaller infarct volumes than WT mice
(Fig 1B, P,0.05, n=7–15). There were no detectable infarcts in
sham-operated WT mice (data not shown). Edema volume also
tended to be smaller in Nox2
-/- mice (6.664.2 mm
3) compared
with WT mice (11.862.2 mm
3; P=0.13).
Superoxide production by middle cerebral arteries
In arteries isolated from WT mice 24 h after MCAO, basal
superoxide production by ischemic MCA was ,3-fold greater
than levels generated by contralateral MCA, or by MCA from
Figure 1. Effect of middle cerebral artery occlusion on cerebral blood flow and infarct volume. Regional cerebral blood flow (rCBF; n=7
for sham, n=60 for wild-type and n=22 for Nox2
-/-; A) and infarct volumes at 24 h following middle cerebral artery occlusion (MCAO; B) in wild-type
and Nox2-deficient (Nox2
-/-) mice. rCBF was measured during MCAO and during reperfusion (30 min). Representative (n=15 for wild type and n=7
for Nox2
-/-) coronal brain sections are shown for wild-type and Nox2
-/- mice at 24 h after MCAO with the infarct area outlined in white (B, top). All
results are presented as mean6SEM. *P,0.05 vs. wild-type (unpaired t test).
doi:10.1371/journal.pone.0028393.g001
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ischemic MCA from Nox2
-/- mice, basal superoxide production
was not elevated compared with contralateral MCA (Fig 2B).
In ischemic MCA from WT mice the Nox2 activator, PDB,
profoundly increased superoxide production by ,50-fold above
basal levels (ischemic MCA: basal 52613 vs. PDB 27846689
10
3 counts/mg; P,0.05, n=9, Figs 2A, 2C). PDB-stimulated
superoxide levels were ,6-fold greater in ischemic MCA than in
contralateral MCA, and in MCA from sham-operated WT mice
(Fig 2C; P,0.05 ischemic vs. contralateral and sham). In Nox2
-/-
vessels after MCAO, PDB did not increase superoxide production
above basal levels (ischemic MCA: basal 2063 vs. PDB 1867
10
3 counts/mg, n=6, Figs 2B, 2D), indicating that PDB
selectively increases superoxide by activating Nox2 oxidase.
Middle cerebral artery nitric oxide function
During the equilibration period, MCA did not develop
significant myogenic tone. Final baseline diameters of ischemic
and contralateral MCA were similar between all groups (WT
ischemic, 12262 mm; WT contralateral, 11863 mm; Nox2
-/-
ischemic, 11168 mm; Nox2
-/- contralateral, 11465 mm). The
magnitude of L-NAME-induced constriction of ischemic MCA
from WT mice was ,50% of that in contralateral MCA
(Figure 3A, P,0.05) indicative of reduced NO function following
ischemia-reperfusion. By contrast, in ischemic MCAs from
Nox2
-/- mice constrictor responses to L-NAME were similar to
those in contralateral MCA (Fig 3B). We also found that
constrictor responses to phenylephrine were significantly greater
in ischemic MCA from WT mice compared with contralateral
MCA (Fig 3C, P,0.05), also indicative of reduced NO function
after ischemia-reperfusion, whereas constrictor responses to
U46619 did not differ between ischemic and contralateral MCA
(Fig 3D).
Nox2, 3-nitrotyrosine, eNOS, and CD45 expression
Using homogenates of ischemic and contralateral MCA from
Nox2
-/- mice subjected to MCAO as a negative control, we found
Nox2 to run as a single band at ,58 kDa in WT MCA (Fig 4).
Figure 2. Effect of cerebral ischemia-reperfusion on vascular superoxide production. Basal (A and B) and phorbol-12, 13-dibutyrate
(10 mmol/L; PDB: Nox2 activator)-stimulated (C and D) superoxide production by middle cerebral arteries (MCA) as measured by 100 mmol/L L-012-
enhanced chemiluminescence. A. Contralateral and ischemic MCA from wild-type mice 24 h after MCA occlusion, and pooled left and right MCA from
sham-operated wild-type mice. B. Contralateral and ischemic MCA from Nox2-deficient (Nox2
-/-) mice 24 h after MCAO. C. Contralateral and ischemic
MCA from wild-type mice 24 h after MCA occlusion (MCAO), and pooled left and right MCA from sham operated wild-type mice. D. Contralateral and
ischemic MCA from Nox2
-/- 24 h after MCAO. All results are expressed as 10
3 counts/mg of dry tissue weight and given as mean6SEM (A and C, n=9
for both groups of MCAO; n=7 for sham; B and D, n=6 for both groups). *P,0.05 vs. contralateral MCA (one way ANOVA with a Bonferroni mutiple
comparison post hoc test).
doi:10.1371/journal.pone.0028393.g002
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of ischemic MCA from WT mice than in contralateral MCA (Fig 4,
P,0.05). In MCA homogenates from WT and Nox2
-/- mice
following MCAO, 3-nitrotyrosine immunoreactive bands (indica-
tive of peroxynitrite production and protein nitration) were
observed between 15 kDa and 150 kDa. Analysis of all bands
within this range revealed that in WT mice, 3-nitrotyrosine levels
were ,1.5-fold higher in ischemic than in contralateral MCA
(Fig 5A, B). By contrast, in Nox2
-/- mice, 3-nitrotyrosine levels
were comparable between ischemic and contralateral MCA
(Fig 5A, B), and similar to levels in contralateral MCA from WT
mice. Protein expression of eNOS was similar between all groups
(WT ischemic, 0.9960.16; WT contralateral, 1.0460.14; Nox2
-/-
ischemic, 1.0260.12; Nox2
-/- contralateral, 1.0260.08 relative
expression to b-actin, n=5 each group, P.0.05). CD45 (a pan
leukocyte marker) is reported to migrate with apparent molecular
weights of 150–250 kDa in mice, depending on the isoform and
the extent of glycosylation.[28] Indeed, four CD45 immunoreac-
tive bands were observed between 150–250 kDa in spleen
homogenates (Fig 6). In ischemic, contralateral and sham MCA
homogenates, immunoreactive bands were observed at approxi-
mately 160, 170, 200 and 230 kDa, however only the 200 kDa
band corresponded to a band detected in the spleen positive
control (Fig 6). The intensity of this band did not appear different
between sham, contralateral and ischemic MCA homogenates.
Discussion
The findings of this study collectively provide the first
demonstration that cerebral ischemia-reperfusion induces oxida-
tive/nitrosative stress and endothelial dysfunction via increased
expression and activity of Nox2 oxidase in the cerebral artery wall.
Firstly, following MCAO in WT mice, superoxide production in
the ischemic MCA was selectively and markedly augmented under
basal conditions and in response to a Nox2 oxidase activator.
Secondly, using an inhibitor of NOS in studies of vascular
function, we found evidence that NO bioavailability and/or
function was selectively attenuated in the ischemic MCA of WT
mice. Thirdly, the oxidative stress and endothelial dysfunction in
the ischemic MCA were associated with higher levels of protein
tyrosine nitration and of Nox2 protein, the catalytic subunit of an
isoform of NADPH oxidase that is highly expressed in the
endothelium. Fourthly, we found that none of the changes
observed after MCAO in the ischemic artery of WT mice were
present in ischemic arteries of Nox2
-/- mice. These findings
definitively demonstrate that both the activity and expression of
Nox2 oxidase are increased in the cerebral circulation following
ischemia-reperfusion, leading to ROS-dependent endothelial
dysfunction and protein damage.
It is likely that dysregulation of the cerebral circulation
compromises perfusion of the post-ischemic brain, and would
Figure 3. Effect of cerebral ischemia-reperfusion on vascular function. Vasoconstrictor responses of isolated contralateral and ischemic
middle cerebral arteries (MCA) from wild-type (A) and Nox2-deficient (Nox2
-/-; B) mice to L-NAME (100 mmol/L) 24 h after MCA occlusion. Also shown
are vasoconstrictor responses of contralateral and ischemic MCA from wild-type mice to phenylephrine (PE: 1 nmol/L-1 mmol/L; C) and U46619
(1 nmol/L-1 mmol/L; D). Results are expressed as% change in intraluminal diameter and given as mean6SEM (A, n=9 for contralateral, n=10 for
ischemic; B, n=6 for contralateral, n=6 for ischemic; C, n=6 for contralateral, n=4 for ischemic; D, n=7 for contralateral, n=6 for ischemic). *P,0.05
vs. contralateral MCA (A: unpaired t test; C: two-way ANOVA with a Bonferroni multiple comparison post-hoc test).
doi:10.1371/journal.pone.0028393.g003
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of vascular cognitive impairment and secondary stroke. While
much research has sought to understand the mechanisms of
primary neuronal injury following stroke, relatively little attention
has been devoted to the identification of factors that cause
cerebrovascular dysfunction. It is known that superoxide levels in
the cerebral circulation increase dramatically during the initial
stages of post-ischemic reperfusion [7,9,10,11], and that this state
of oxidative stress may persist for several days [8]. Nox2 oxidase is
one of five isoforms of the NADPH oxidase family of ROS-
generating enzymes, and is emerging as a major mediator of
oxidative stress and dysfunction in the cerebral circulation during
a number of disease states [12,14,15,16,17]. Nox2 oxidase is
primarily expressed in the endothelium of blood vessels and is
capable of generating relatively large amounts of superoxide,
analogous to the NADPH oxidase in phagocytes responsible for
the respiratory burst [12]. We have previously reported that
superoxide levels in the cerebral circulation are normally much
higher than in a range of systemic arteries [29,30], which could
result in a relatively lower threshold for oxidative toxicity existing
in cerebral vessels when superoxide levels are raised above normal
during disease. Importantly, when generated in the same
biological compartment, superoxide reacts avidly with NO leading
to decreased NO bioavailability and the formation of peroxyni-
trite, a highly reactive and damaging species that causes nitration
of tyrosine residues on proteins. Thus, increased activity of Nox2
oxidase in endothelial cells could lead to substantial superoxide
production resulting in inactivation of endothelium-derived NO
and generation of peroxynitrite.
In the present study we first sought to test whether superoxide
production is elevated in the mouse cerebral circulation after
ischemia-reperfusion. We found that basal superoxide levels in the
ischemic MCA of WT mice were substantially greater (,3-fold)
than in the contralateral MCA or in MCA from sham-operated
mice. We also found that superoxide production in the ischemic
MCA could be profoundly augmented by a stimulus of Nox2
oxidase (i.e. PDB), and that this effect was much greater than that
observed in non-ischemic contralateral arteries. As mentioned,
endothelial dysfunction is a major pathological consequence of
vascular oxidative stress and occurs in part via the superoxide-
dependent interruption of NO signaling. In the setting of post-
ischemic reperfusion, diminished NO function has been reported
to occur in the cerebral circulation [10,31,32], but the role of
Nox2 oxidase in such dysfunction has not been examined. To
address this question, we next obtained strong functional evidence
for impaired NO-mediated function in mouse cerebral arteries
after MCAO. Specifically, we found that L-NAME-induced
vasoconstriction was selectively attenuated in the ischemic arteries
of WT mice. Furthermore, constrictor responses to an a-
adrenoceptor agonist (which are typically modulated by endothe-
lium-derived NO [33]) were significantly augmented in those
vessels, whereas constrictor responses to a thromboxane A2
mimetic were unaffected. Moreover, we found that there were
increased levels of 3-nitrotyrosine in ischemic arteries from WT
mice, indicative of protein nitration by peroxynitrite and thus
inactivation of NO by superoxide.
Todirectlytestwhetherincreased Nox2oxidase activityunderlies
these detrimental effects of ischemia-reperfusion on the cerebral
artery wall, we performed equivalent MCAO studies in Nox2
-/-
mice. In contrast to WT mice, we found that basal superoxide levels
were not elevated in the ischemic MCA from Nox2
-/- mice.
Moreover, PDB failed to increase superoxide levels above basal
levels in either ischemic or contralateral MCA from Nox2
-/- mice,
verifying that PDB increasescerebrovascularsuperoxide production
by selectively activating Nox2 oxidase. Consistent with these
findings, there were also no abnormalities of constrictor responses
to L-NAME, nor were there increased 3-nitrotyrosine levels in
ischemicarteries from Nox2
-/-mice.Thus, ourdataprovidethefirst
direct and definitive evidence that Nox2 oxidase is the key mediator
of augmented superoxide production, endothelial dysfunction and
nitrosative stress following cerebral ischemia-reperfusion.
There is good evidence from studies on Nox2 oxidase-deficient
mice that elevated activity of this isoform contributes to neuronal
injury following ischemic stroke [18,21,34,35], and that the
protective effects of the Nox oxidase inhibitor apocynin occur
via inhibition of this Nox isoform [19,20]. More recently, evidence
for a role for Nox4 oxidase-derived ROS in neuronal damage has
also been reported, whereby genetic deletion or pharmacological
inhibition of Nox4 oxidase conferred neuroprotection in perma-
nent and transient models of cerebral ischemia [36]. By contrast,
there is divided evidence as to whether Nox1 oxidase activity
contributes to stroke damage [36,37,38]. Consistent with previous
studies of Nox2
-/- mice, we found in the present study that infarct
volume and neurological impairment were markedly reduced in
Nox2
-/- versus WT mice. However, our additional findings that
the vascular dysfunction that occurs in the cerebral circulation
following ischemic stroke is also Nox2-dependent raises the
possibility that the preservation of vascular function, in addition
Figure 4. Effect of cerebral ischemia-reperfusion on vascular
Nox2 expression. Representative Western blots (top) showing
protein expression of Nox2 in contralateral (Contra) and ischemic (Isch)
middle cerebral artery homogenates from wild-type and Nox2-deficient
(Nox2
-/-) mice at 24 h after MCA occlusion. Also shown is a summary of
immunoreactive band intensity (bottom). Values are expressed as
relative intensity normalized to b-actin intensity, and are given as
mean6SEM (n=4 for all groups). *P,0.05 vs. contralateral (one sample
t-test).
doi:10.1371/journal.pone.0028393.g004
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to the broader beneficial effects of Nox2 oxidase deletion and/or
inhibition after ischemic stroke.
To explore a possible molecular basis for augmented Nox2-
dependent superoxide levels, we examined the effect of ischemia-
reperfusion on cerebral artery Nox2 expression. Using Western
blotting, we observed a Nox2 immunoreactive band at approx-
imately 58 kDa in MCA homogenates from ischemic and non-
ischemic cerebral hemispheres of WT mice, which was absent in
homogenates of MCA from Nox2
-/- mice. Analysis of this band
revealed that expression levels were ,1.4-fold higher in ischemic
versus non-ischemic arteries. It has been reported that cerebral
ischemia-reperfusion is associated with immune cell adhesion and
accumulation of inflammatory cells in the cerebral vasculature and
brain.[6,39,40] Leukocytes express a functionally active Nox2
oxidase [12], and thus, it is conceivable that adherent/infiltrating
leukocytes may contribute to the augmented cerebral vascular
superoxide production following ischemia-reperfusion. Therefore,
to test this we next measured expression levels of the pan leukocyte
marker CD45 in MCA following ischemia-reperfusion. Using
Figure 5. Effect of cerebral ischemia-reperfusion on vascular 3-nitrotyrosine levels. Representative Western blots (A) showing expression
of 3-nitrotyrosine in contralateral (Contra) and ischemic (Isch) middle cerebral artery homogenates from wild-type and Nox2-deficient (Nox2
-/-) mice
at 24 h after MCA occlusion. Also shown is a summary of immunoreactive band intensity (bottom). Values are expressed as relative intensity
normalized to b-actin intensity, and are given as mean6SEM (n=5 for all groups). *P,0.05 vs contralateral (one-way ANOVA with a Bonferroni
multiple comparison post-hoc test).
doi:10.1371/journal.pone.0028393.g005
Figure 6. Effect of ischemia-reperfusion on CD45 expression in cerebral arteries. Western blots (n=2) showing CD45 levels in sham,
contralateral (Contra) and ischemic (Isch) middle cerebral artery homogenates from wild-type mice at 24 h after MCA occlusion. Spleen homogenates
were used as positive controls. MCA homogenates from 5 mice were pooled in order to obtain sufficient protein levels.
doi:10.1371/journal.pone.0028393.g006
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immunoreactive band in contralateral and ischemic MCA
homogenates. However, it did not appear that there were
differences in the relative levels of CD45 between contralateral
and ischemic MCA. Thus, it appears unlikely that increased
leukocyte adherence/infiltration accounts for the Nox2-dependent
changes following ischemia-reperfusion, but instead point towards
increased vascular cell Nox2 oxidase expression/activity -
probably in endothelium - as the main contributing factor.
Mechanisms that regulate Nox2 oxidase expression and/or
activity in cerebral arteries after stroke remain to be examined.
Recently, casein kinase 2 (CK2) was identified as a negative
regulator of NADPH oxidase [41]. Interestingly, CK2 activity is
rapidly reduced in mouse brains during ischemia-reperfusion,
leading to an increase in NADPH oxidase activity and expression
of Nox2 [41]. Thus, dysregulation of CK2 may be an important
underlying cause of NADPH oxidase-driven neuronal injury in
ischemic stroke [41]. If such a relationship also exists between
CK2 and Nox2 oxidase in cerebral arteries, it may similarly
contribute to elevations in cerebrovascular Nox2 oxidase activity
after ischemia-reperfusion. Increased expression of endothelin and
angiotensin receptors is reported to occur in the cerebral
vasculature after ischemic stroke [2], and indeed stroke is
associated with elevated production of pro-inflammatory cyto-
kines, endothelin-1 and angiotensin II [2,42] – all of which can
increase the activity and expression of NADPH oxidases. Thus, it
is plausible that several mechanisms may influence Nox2
expression and activity in the cerebral vasculature after stroke.
In summary, we have provided evidence that vascular Nox2
oxidase plays a critical role in elevated superoxide production by
cerebral arteries following ischemia-reperfusion. This increase in
vascular Nox2 oxidase-derived superoxide appears to cause
impaired endothelium-dependent, NO-mediated vasodilator func-
tion, most likely via the direct inactivation of NO and the
formation of peroxynitrite. The ultimate impact of Nox2 oxidase-
mediated endothelial dysfunction on stroke outcome remains to be
clarified, however, these studies highlight vascular Nox2 oxidase as
a potential novel vaso- and neuro-protective target for stroke
therapy.
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